Recently, we were the first to show that AT1R is expressed in human ovarian cancer cells and angiotensin II enhanced tumour cell invasion and VEGF expression/secretion via AT1R (Suganuma et al, 2005). This evidence concerns the gene VEGFA and ovarian carcinoma.